溴隐亭治疗迟发运动障碍的双盲自身对照试验  

A Double-blind Auto-control Study on the Effect of Bromocriptine on Tardive Dyskinesia

作　　者：陈景清 郑先振 曹中昌 刘华 

机构地区：[1]山东济宁精神病防冶院,272151

出　　处：《药物流行病学杂志》1995年第4期203-205,共3页Chinese Journal of Pharmacoepidemiology

摘　　要：采用双盲自身对照的方法观察溴隐亭与安慰剂治疗迟发运动障碍的疗效.以AIMS为评定工具,对每对受试者用开放型序贯试验进行统计分析,结果显示溴隐亭治疗迟发运动障碍优于安慰剂,并未见严重不良反应.The effects of bromocriptine and placebo on tardive dyskinesia (TD) were observed in a double-blind auto-control study. AIMS was employed for assessment. An open sequential test for each pair of matched subjects revealed that bromoriptine was superior to placebo in the treatment of TD with an improvement rate of 70%. No serious untoward effect was found-

关 键 词：迟发性运行障碍 药源性精神障碍 

分 类 号：R749.610.5[医药卫生—神经病学与精神病学] R977[医药卫生—临床医学]